Skip to main navigation Skip to search Skip to main content

Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

  • Frank L van de Veerdonk
  • , Ilse J E Kouijzer
  • , Aline H de Nooijer
  • , Hans G van der Hoeven
  • , Coen Maas
  • , Mihai G Netea
  • , Roger J M Brüggemann

Research output: Contribution to journalLetterAcademicpeer-review

4 Downloads (Pure)
Original languageEnglish
Article numbere2017708
JournalJAMA network open
Volume3
Issue number8
DOIs
Publication statusPublished - 13 Aug 2020

Keywords

  • Adult
  • Aged
  • Betacoronavirus
  • Bradykinin B2 Receptor Antagonists/therapeutic use
  • Bradykinin/analogs & derivatives
  • Coronavirus Infections/drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxygen/blood
  • Pandemics
  • Pneumonia, Viral/drug therapy
  • Receptor, Bradykinin B2/metabolism

Cite this